Health
Psychedelic Drugmaker Definium Surges on Depression Drug Success
Key Points
Psychedelic Drugmaker Definium Surges on Depression Drug Success Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders. Piper Sandler analyst David Amsellem said the latest data reinforce his view that the drug should emerge as a “best-in-class” option for patients with the disorder who haven’t had significant experience with...
Psychedelic Drugmaker Definium Surges on Depression Drug Success
Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders.
Piper Sandler analyst David Amsellem said the latest data reinforce his view that the drug should emerge as a “best-in-class” option for patients with the disorder who haven’t had significant experience with conventional treatments.